Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · technology

Sanyou Bio Launches AI-Powered Clicklinks to Accelerate Global Drug Discovery and ...

31 August 2026 · By · Wire by Fusion42

Published

31 August 2026

Topic

technology

◆ Sectors

BiotechDrug Discovery

◆ Source

Read at biopharmaapac.com →

◆ Verified

Fusion42 · 31 August 2026 · Fusion42 review

Sanyou Bio launched Clicklinks, an AI-powered collaborative network integrating nearly 70 technology platforms across the drug R&D value chain to accelerate global drug discovery and preclinical development through diverse global partnerships.

This Wire brief sits within Fusion42's coverage of Biotech and Drug Discovery.

◆ ◆ The Wire takeaway

Your drug discovery efforts can now plug into a ready-made AI-powered platform that combines diverse expertise and technology under one portal. This opens the door to faster validation and scaling through established partners rather than building everything from scratch.

◆ Coverage

1 source · 31 Aug 2026

◆ Related on Wire

◆ Topics

BiotechDrug Discoveryai-in-healthdrug-discoverycollaboration-platformpreclinical-developmentbiopharmainnovation-hub